BoC slashes rates as building permits plunge – AstraZeneca’s $820M bet and Starlight’s real estate takeover

In this episode, Steven Hamoen begins with an introduction and provides economic updates relevant to the commercial real estate landscape. He discusses AstraZeneca's significant investment in Canada, analyzing its potential impact on the real estate sector, particularly in life sciences and associated industries. The conversation then shifts to Starlight Investments, highlighting its recent growth and strategic initiatives within the commercial real estate market. Steven concludes with closing remarks, encouraging listeners to consider these developments in their investment strategies.